** Shares of Ansell rise as much as 4.7% to A$32.900, hitting their highest level since Jan 25, 2022
** Stock set for strongest trading session since late August
** Medical equipments supplier revises FY25 adj EPS outlook range to 110-127 US cents from 107-127 US cents
** However, co says higher inflation costs of key raw materials and higher freight costs to have greater impact in H2 FY25
** Stock up 24.8% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.